Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,303 total articles
Solomon Moshkevich, the President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), has completed a series of stock transactions involving 3,405 shares of company common stock. These sales, executed on May 1, 2026, represent a total transaction value of $693,559. The price per share for these disposals fluctuated between $200.9523 and $206.93.…
William Brian Poppic Reeves, serving as Chief Executive Officer and maintaining a 10% ownership stake in Fold Holdings, Inc. (NASDAQ: FLD), has completed a sale of common stock intended to satisfy tax obligations. The transaction, which took place on May 4, 2026, involved the sale of 5,537 shares at a price point of $1.422 per share, resulting in t…
Daniel Rabinowitz, serving as Secretary and Chief Legal Officer for Natera, Inc. (NASDAQ: NTRA), completed a sale of 330 shares of common stock on May 1, 2026. The transaction, valued at $206.16 per share, totaled $68,032. This divestment was not an open-market discretionary trade but was conducted to meet tax withholding and remittance requirement…
Steven Leonard Chapman, the President and Chief Executive Officer of Natera, Inc. (NASDAQ:NTRA), has completed a disposal of company common stock totaling $185,956. The transaction, which took place on May 1, 2026, involved the sale of 902 shares at a per-share price of $206.16. This movement comes as Natera prepares to report its earnings on May 7…
Natera, Inc. (NASDAQ:NTRA) has disclosed a recent insider transaction involving its President and Chief Business Officer, John Fesko. On May 1, 2026, Mr. Fesko sold 291 shares of the company's common stock for a total value of $59,992. The sale was executed at a price point of $206.16 per share.The transaction was not an open-market discretionary t…
Repass Wolfe, the Chief Financial Officer of Fold Holdings, Inc. (NASDAQ: FLD), has completed a transaction involving the sale of common stock to address tax obligations. This activity follows a recent acquisition of shares through the vesting and conversion of restricted stock units. The transactions occur as the company prepares for its upcoming …
Thomas J. Dickman, the Chief Technology Officer of Fold Holdings, Inc. (NASDAQ: FLD), has completed a transaction involving the sale of company stock. The disposal, reported on May 4, 2026, was not a discretionary market move but rather a mandatory 'sell to cover' action intended to meet tax withholding requirements following the vesting and settle…
George Kurtz, the President and Chief Executive Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), has completed a sale of Class A common stock valued at approximately $1.35 million. The transaction, which took place on May 4, 2026, involves the disposal of 2,882 shares. This insider activity comes amid a period of operational expansion for the c…
George Kurtz, the President and CEO of cybersecurity leader CrowdStrike Holdings, Inc. (NASDAQ:CRWD), has completed a series of stock transactions totaling approximately $4,172,433. The sales, which occurred on May 1 and May 4, 2026, involved 9,109 shares of the company's Class A common stock at prices ranging from $446.71 to $471.21 per share. The…
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) saw insider activity this week as Chief Financial Officer Burt W. Podbere sold a portion of his Class A common stock. The transaction, valued at $883,799, involved the sale of 1,933 shares on May 4, 2026. While such transactions often draw market attention, the sale was conducted to satisfy tax withholdings …
Christopher Riley, serving as the General Counsel and Secretary for Playboy, Inc. (NASDAQ: PLBY), has completed two separate transactions involving the sale of company common stock. These sales, which occurred on May 4 and May 5, 2026, resulted in a total liquidation value of $320,083. The transactions were specifically structured to cover tax with…
Martin E. Stein Jr., serving as the executive chairman of Regency Centers Corp. (NASDAQ: REG), has completed the sale of 274,615 shares of common stock. The total value realized from these transactions is approximately $21.5 million. According to recent regulatory filings, these sales took place on May 4, 2026, with share prices fluctuating between…
Andrew Pardo Wright, a director at Slide Insurance Holdings, Inc. (OTC:SLDE), completed a sale of company common stock on May 1, 2026. The transaction, totaling $281,250, involved the sale of 15,000 shares at a price point of $18.75 per share. These shares were held indirectly via MAOV Slide, LLC, an entity under Mr. Wright's control. While he main…
SentinelOne, Inc. President and CEO Tomer Weingarten has completed a series of stock transactions totaling approximately $3.55 million in early May. The sales, which involved over 231,000 shares of Class A common stock, were conducted through a pre-arranged Rule 10b5-1 trading plan established on June 3, 2025. This insider activity occurs amidst a …
Mark L. Jacobson, the Chief Operating Officer of Axsome Therapeutics, Inc. (NASDAQ:AXSM), completed a series of stock transactions totaling approximately $1,082,770. The sales took place over two consecutive days in early May 2026 and were conducted under a pre-approved 10b5-1 trading plan. These transactions involved the immediate sale of shares f…
Howard G. Welgus, a member of the board of directors at Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), has completed a sale of common stock totaling roughly $164,219. The transaction involved 7,144 shares and was executed on May 1, 2026. This divestment occurred through several individual transactions, with share prices fluctuating between $22.79 and…
Nancy A. Grygiel, who serves as the Senior Vice President and Chief Compliance Officer at Amgen Inc (NASDAQ: AMGN), has completed two recent transactions involving her holdings in the biotechnology company. These disposals occurred in early May 2026, marking a shift in her direct and indirect equity position within the firm. While these individual …
David Mountcastle, the Executive Vice President and Chief Financial Officer of Privia Health Group, Inc. (NASDAQ:PRVA), has completed a series of stock transactions involving both the exercise of options and the subsequent sale of common shares. The activity, which took place in early May 2026, resulted in total sales of approximately $209,840. The…
William F. Kimble, the Chairman of the Board for Liberty Energy Inc. (LBRT), has completed a sale of company stock. On May 5, 2026, Kimble disposed of 7,350 shares of Class A Common Stock. The transaction was conducted at a price point of $33.92 per share, resulting in total proceeds of $249,312. This movement comes as the company's stock maintains…
Georges Antoun, the Chief Commercial Officer at First Solar, Inc. (NASDAQ:FSLR), has completed a sale of company common stock totaling $122,046. The transaction occurred on May 5, 2026, involving the sale of 566 shares at a price of $215.63 per share. This specific divestment was conducted to address tax withholding requirements that arose from the…
Patrick James Buehler, the Chief Product Officer at solar technology firm First Solar, Inc. (NASDAQ: FSLR), has completed a series of transactions involving the company's common stock. These activities, which took place on May 4 and May 5, 2026, involved both the acquisition of new shares through equity vesting and the subsequent sale of a portion …
Michael Koralewski, who serves as the Chief Supply Chain Officer for First Solar, Inc. (NASDAQ:FSLR), has completed a sale of common stock totaling approximately $46,360. The transaction occurred on May 5, 2026, involving the sale of 215 shares at a price point of $215.63 per share.This divestment was closely linked to the vesting of restricted sto…
Bradley Alexander, the Chief Financial Officer of First Solar, Inc. (NASDAQ:FSLR), has completed a transaction involving the sale of company stock. The sale, which occurred on May 5, 2026, was tied to tax obligations arising from the vesting of restricted stock units. This activity comes amidst a period of notable price movement for FSLR, which has…
Hans van Houte, the Chief Financial Officer of Nurix Therapeutics, Inc. (NASDAQ: NRIX), has completed a series of stock transactions totaling $233,318. The sales, which took place on May 5, 2026, were conducted through a pre-established Rule 10b5-1 trading plan. This movement of capital occurs as the biotechnology firm continues to advance its onco…
Adam Crystal, who serves as the President of Research & Development at Tango Therapeutics, Inc. (NASDAQ: TNGX), has completed a series of stock transactions totaling $573,097. The disposals occurred on May 1, 2026, and were executed in conjunction with the exercise of stock options. These moves were conducted under a Rule 10b5-1 trading plan that w…
